• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

M&A: HEALWELL AI Acquires Pentavere Research Group to Enhance AI Healthcare Solutions

by Health M&A Moves 11/17/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
HEALWELL AI Acquires Pentavere Research Group to Enhance AI Healthcare Solutions

What You Should Know:

– HEALWELL AI Inc. (TSX: AIDX), a data science and AI company focused on preventative care, has announced a significant step forward in its mission to revolutionize healthcare through the acquisition of a majority ownership position in Pentavere Research Group Inc. (Pentavere).

– This acquisition will bolster HEALWELL’s AI technology capabilities and expand its reach in the healthcare industry.

Pentavere Background

Pentavere, an innovative AI health-tech company based in Toronto, Ontario, specializes in identifying eligible patients for approved medications and interventions. Its expertise in data abstraction and structuring, coupled with its extensive network and experience in hospital specialist care, aligns perfectly with HEALWELL’s commitment to improving preventative care.

Acquisition Benefits for HEALWELL AI

The proposed majority acquisition of Pentavere will bring several benefits to HEALWELL:

– Top-line revenue growth: Pentavere’s established client base and proven track record of commercializing real-world evidence studies will contribute to HEALWELL’s top-line revenue.

– Expanded product portfolio: Pentavere’s AI-driven solutions will add to HEALWELL’s existing product offerings, providing a more comprehensive suite of AI-powered healthcare solutions.

– Strengthened partnerships: Pentavere’s strong relationships with major hospital networks in Canada and the United States will expand HEALWELL’s reach and provide access to new patient populations.

– Enhanced AI expertise: Pentavere’s team of AI engineers will bring valuable expertise to HEALWELL, further strengthening the company’s technological capabilities.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |